Oral Solid Dose 2015 - Issues with Risk Assessments for Cross Contamination of OSD Facilities

Overview: Oral Solid Dosage is the most difficult of the pharmaceutical processes to protect from cross contamination and the webinar will show why this is. The webinar will explore the typical processes used in Oral Solid Dosage. Equipment issues will be explored and critical issues outlined We will look at facility, HVAC and equipment issues.
Why should you attend: Using data the case for OSD being outstandingly the greatest risk will be made and the reasoning explained
If you are a CMO it will help to get you ahead of what is about to happen staring March 1st 2015.
The routes of cross contamination will be reviewed with emphasis on cleaning due the high surface to volume ratios encountered.
The majority of CMO' we interact with do not understand what is happening and why they need to plan for the new requirements even if they do not supply the EU. As part of the webinar a brief review of what is happening with regulators around the world be included.
Areas Covered in the Session:
Briefly review the new regulations
Why Oral Solid Dose is a problem
The importance of boundaries in facility design
The importance of HVAC
Why liquids are so much easier that powders
Closing powder handling processes
It's not just about cleaning
Who Will Benefit:
Directors
Senior Managers in the Quality and Regulatory Areas
Senior Managers of Operations
Engineering and for CMO Business Development Leadership
Julian Wilkins was educated as an Architect in the United Kingdom.. He practiced as an architect and project team manager for IDC now AMEC from 1972 to 1988. From 1978 onwards all the projects he handled where for the pharmaceutical industry.
MentorHealth
Roger Steven
contact no: 8003851607
fax no: 302-288-6884
Event Link:http://bit.ly/1DTiNzL
webinars-AT-mentorhealth.com
www.mentorhealth.com